pretickt

When does Merck report earnings?

Merck & Co., Inc. · end-of-day data as of Nov 13, 2026

Merck
MRK · $364B
$147.76+0.6%
Nov 13, 2026 · close
$140$150SepOctNov9:3016:003 months +10.0%Nov 13 · close
▲ 9
  • PT$159.63 +8.0%
  • ConsensusBuy · 28
  • FCF yield+4.0%
  • News
  • Trendbullish
  • MAs4 of 4
  • MA20×50Golden 3d ago
  • MACD0.09
  • Sector▲ +15.9%
Neutral
  • Earnings in81d
  • P/E152.3x
  • RSI53
  • Support-4.5%
  • Resistance+1.4%
  • Off 52w high-5.8%
  • Volume0.7x
  • Bollingerupper half
  • 52w range$91–$157
  • ATR+2.8%
  • Off ATH-5.8%
  • InsidersNone in 90d
▼ 2
  • P/E vs own+102.5%
  • P/E vs sector+372.9%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Merck MRK reports its next earnings on Tuesday, Feb 2, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of $1.78 on revenue of $16.29B. Merck beat the EPS estimate in 6 of its last 8 reports, and the stock moved ±2.5% on average the session after. The last report, on Oct 29, 2026: EPS of $2.49 against $2.09 expected and revenue of $18.09B against $17.33B; the stock rose 3.8% the next session.

The stock around its reports

⇔⇕$75.54$100$125$150Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26DAAEADEADEDAEADAAEDEDEAADEE

Last close $147.76 · +56.6% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +5.2% year over year, free cash flow 30.5% of revenue, operating margin 40.6%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$18.09B2.04$5.52B81.4%40.6%28.0%
Q2 FY2026Jun 30, 2026$16.61B-0.54$4.48B73.5%-4.1%-8.0%
Q1 FY2026Mar 31, 2026$16.29B-1.72$2.93B81.9%-11.6%-26.0%
Q4 FY2025Dec 31, 2025$16.32B1.19$1.82B70.5%37.7%18.2%
Q3 FY2025Sep 30, 2025$17.18B2.32$6.83B75.6%43.4%33.7%
Q2 FY2025Jun 30, 2025$15.8B1.76$2.53B75.7%40.2%28.0%
Q1 FY2025Mar 31, 2025$15.62B2.01$1.17B75.1%43.0%32.5%
Q4 FY2024Dec 31, 2024$15.62B1.48$2.51B75.5%27.8%24.0%